CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

Clinical trial NCT04257175 · UNKNOWN

Trial details

NCT number: NCT04257175
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2020-02-18
Primary completion: 2024-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.